ACTISOUFRE 4 mg/50 mg per 10 ml oral/nasal suspension

 VIDAL pharmacotherapeutic classification:

Oto - Rhino - Laryngology : Adjuvant drugs in ENT disorders ( Sulfur drugs )

ATC classification:RESPIRATORY SYSTEM : COLD AND COUGH DRUGS ( OTHER COLD DRUGS )

Substances
sodium monosulfide nonahydrate
saccharomyces cerevisiae

Excipients:

sodium saccharin , polysorbate 80 , sodium chloride , purified water

flavoring:  neroli aroma , petitgrain bigarade essence , sweet orange essence , geraniol , terpineol , linalool , methyl anthranilate , 2-phenylethanol , geranyl acetate

Excipients with known effect :

NRS with threshold dose:  sodium

Presentation

ACTISOUFRE 4 mg/50 mg per 10 ml Susp buv/nas 30Amp/10ml

Cip: 3400932816439

Storage conditions: Before opening: for 36 months (Keep in its packaging)

Not approved for communities

Refund: NR